R. Giri et al. / Tetrahedron: Asymmetry 16 (2005) 3502–3505
3505
1
6. For various examples of stoichiometric cyclopalladation
reactions, see: (a) Canty, A. J. In Comprehensive Organo-
metallic Chemistry II: A Review of the Literature 1982–
1994; Abel, E. W., Stone, F. G. A., Wilkinson, G., Eds.;
Pergamon, 1995; pp 225–255; (b) Balavoine, G.; Clinet,
J. C. J. Organomet. Chem. 1990, 390, C84–C88.
7. (a) Constable, A. G.; McDonald, W. G.; Sawjins, L. C.;
Shaw, B. L. J. Chem. Soc., Chem. Commun. 1978, 1061–
1062; (b) Carr, K.; Sutherland, J. K. J. Chem. Soc., Chem.
Commun. 1984, 1227–1228; (c) Baldwin, J. E.; Jones, R.
H.; Najera, C.; Yus, M. Tetrahedron 1985, 41, 699–711; (d)
Bore, L.; Honda, T.; Gribble, G. W. J. Org. Chem. 2000,
65, 6278–6282.
2.9 ppm was also observed in the H NMR. The down-
1
field shift in H NMR and the distance (H atoms were
placed at idealized geometric positions) between the
methine C–H bond and the Pd center in the crystal
structure (27a)18 rules out the possibility of agostic inter-
actions.19 However, a weaker interaction between PtII
and C–H bonds reported by Pregosin was shown to
result in a downfield shift.20 At this stage, it is unclear
to us as to how this interaction may interfere the C–H
cleavage process. However, this preliminary study, in
combination with the experimental results obtained using
substrates 9–15 suggested that the C–H bonds in the
vicinity of the r-chelating group need to be appropriately
positioned or avoided.
8. (a) Gomez, M.; Granell, J.; Martinez, M. Eur. J. Chem.
2000, 217–224; (b) Dupont, J.; Consorti, C. S.; Spencer, J.
Chem. Rev. 2005, 105, 2527–2572.
9. (a) Desai, L. V.; Hull, K. L.; Sanford, M. S. J. Am. Chem.
Soc. 2004, 126, 9542–9543; (b) Dick, A. R.; Hull, K. L.;
Sanford, M. S. J. Am. Chem. Soc. 2004, 126, 2300–2301.
10. (a) Stahl, S. S.; Labinger, J. A.; Bercaw, J. E. J. Am. Chem.
Soc. 1996, 118, 5961–5976; (b) Fekl, U.; Goldberg, K. I.
J. Am. Chem. Soc. 2002, 124, 6804–6805.
11. (a) Canty, A. J.; Denney, M.; Koten, G.; Skelton, B. W.;
White, A. H. Organometallics 2004, 23, 5432–5439; (b)
Amijs, C. H. M.; Kleij, A. W.; van Klink, G. P. M.; Spek,
A. L.; van Koten, G. Organometallics 2005, 24, 2773–
2779.
We are currently in the process of obtaining crystal
structures of the Pd-alkyl intermediates using a wide
range of prochiral oxazoline substrates. Further optimi-
zation of the oxazoline structures using the structural
information will be carried out in our laboratory in
order to improve the diastereoselectivity with a broad
substrate scope.
Acknowledgments
12. Giri, R.; Chen, X.; Yu, J. Q. Angew. Chem., Int. Ed. 2005,
44, 2112–2115.
13. For various protocols for the preparation of monodentate
oxazolines see: Gomes, M.; Muller, G.; Rocamora, M.
Coord. Chem. Rev. 1999, 193–195, 769–835.
We thank Brandeis University for financial support and
the Camille and Henry Dreyfus Foundation for a New
Faculty Award.
14. For the early use of PhI(OAc)2 as an oxidant for the
acetoxylation of benzene, see: Yoneyama, T.; Crabtree,
R. H. J. Mol. Catal. A-Chem. 1996, 108, 35.
References
15. Typical procedure: Oxazoline (1 mmol) was placed in a
20 mL scintillation vial and dissolved in CH2Cl2 (5 mL).
Palladium acetate (22.4 mg, 0.1 mmol), iodobenzene diac-
etate (322 mg, 1 mmol) and iodine (253.8 mg, 1 mmol)
were added to the solution. The vial was tightly sealed
with a polypropylene lined cap and the resulting violet
solution was either stirred at room temperature or heated
at 50–65 °C until black palladium iodide precipitated out.
The solvent was removed in a rotary evaporator. The
product was purified by silica gel column chromatography
eluting first with hexane to remove iodine and iodobenz-
ene, and then with ethylacetate/hexane 1:20.
1. (a) Groves, J. T.; Viski, P. J. Am. Chem. Soc. 1989, 111,
8537–8538; (b) Punniyamurthy, T.; Katsuki, T. Tetra-
hedron 1999, 55, 9439–9454; (c) Zhou, X. G.; Yu, X. Q.;
Huang, J. S.; Che, C. M. Chem. Commun. 1999, 2377–
2378; (d) Jang, D. O.; Kim, D. D.; Pyun, D. K.; Beak, P.
Org. Lett. 2003, 5, 4155–4157; (e) Kennedy, M.; Mcker-
vey, M. A.; Maguire, A. R.; Roos, G. H. P. J. Chem. Soc.,
Chem. Commun. 1990, 361–362; (f) Doyle, M. P.; Proto-
popova, M. N.; Poulter, C. D.; Rogers, D. H. J. Am.
Chem. Soc. 1995, 117, 7281–7282; (g) Espino, C. G.;
When, P. M.; Chow, J.; Du Bois, J. J. Am. Chem. Soc.
2001, 123, 6935–6936; (h) Davies, H. M. L.; Beckwith, R.
E. J. Chem. Rev. 2003, 103, 2861–2903; (i) Muller, P.;
Fruit, C. Chem. Rev. 2003, 103, 2905–2919.
16. Eaton, P. E.; Daniels, R. G.; Casucci, D.; Cunkle, G. T.
J. Org. Chem. 1987, 52, 2100–2102.
17. Murai has previously tested oxazolines as directing groups
to activate ortho-aryl C–H bonds using a Ru(II) catalyst.
It was concluded that a chiral oxazoline bearing a
hydrogen a to the nitrogen is not suitable for C–H
activation, due to the preferential oxidation of this
hydrogen. For details see: Kakiuchi, F.; Sato, T.; Yama-
uchi, M.; Chatani, N.; Murai, S. Chem. Lett. 1999, 19–20.
18. CCDC number 287801.
2. (a) Johnson, J. A.; Li, N.; Sames, D. J. Am. Chem. Soc.
2002, 124, 6900–6903; (b) Hinman, A.; Du Bois, J. J. Am.
Chem. Soc. 2003, 125, 11510–11511.
3. (a) Dyker, G. Angew. Chem., Int. Ed. 1999, 38, 1699–1712;
(b) Lenges, C. P.; Brookhart, M. J. Am. Chem. Soc. 1999,
121, 6616–6623; (c) Kakiuchi, F.; Murai, S. Acc. Chem.
Res. 2002, 35, 826–834; (d) Kakiuchi, F.; Chatani, N. Adv.
Synth. Catal. 2003, 345, 1077–1101.
19. Crabtree, R. H.; Holt, E. M.; Lavin, M.; Morehouse,
S. M. Inorg. Chem. 1985, 24, 1986–1992.
20. Pregosin, P. S.; Wombacher, F. Magn. Reson. Chem. 1991,
29, S106–S117.
4. (a) Bennett, M. A.; Milner, D. L. J. Am. Chem. Soc. 1969,
91, 6983–6994; (b) Ibers, J. A.; Dicosimo, R.; Whitesides,
G. M. Organometallics 1982, 1, 13–20.
5. Ryabov, A. D. Synthesis 1985, 233–252.